BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pathology News - ECPv6.16.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.pathologynews.com
X-WR-CALDESC:Events for Pathology News
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20240101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/London
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20241027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20261025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20270328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20271031T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/Stockholm
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20261025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20270328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20271031T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/Paris
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20241027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20261025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20270328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20271031T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260408
DTEND;VALUE=DATE:20260412
DTSTAMP:20260826T165820
CREATED:20260115T131319Z
LAST-MODIFIED:20260115T131355Z
UID:100117905-1775606400-1775951999@www.pathologynews.com
SUMMARY:International Symposium on Biomedical Imaging 2026
DESCRIPTION:0000Days00Hrs00Min00SecThe IEEE International Symposium on Biomedical Imaging (ISBI) is a premier scientific conference dedicated to the mathematical\, algorithmic\, and computational aspects of biological and biomedical imaging across all scales of observation. \nIt fosters knowledge transfer among different imaging communities and contributes to an integrative approach to biomedical imaging. ISBI is a joint initiative of the IEEE Signal Processing Society (SPS) and the IEEE Engineering in Medicine and Biology Society (EMBS). \nRegister Now
URL:https://www.pathologynews.com/event/international-symposium-on-biomedical-imaging-2026/
LOCATION:The ICC Capital Suite at ExCeL London\, Royal Victoria Dock\, 1 Western Gateway\, London\, e16 1xl\, United Kingdom
CATEGORIES:In Person Event
ATTACH;FMTTYPE=image/jpeg:https://www.pathologynews.com/wp-content/uploads/2026/01/International-Symposium-on-Biomedical-Imaging.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20260331T150000
DTEND;TZID=Europe/London:20260331T160000
DTSTAMP:20260826T165820
CREATED:20260302T135657Z
LAST-MODIFIED:20260302T135657Z
UID:100119049-1774969200-1774972800@www.pathologynews.com
SUMMARY:Masterclass: Unlock Cell Population Discovery Using HALO® High Dimensional Analysis
DESCRIPTION:0000Days00Hrs00Min00SecThe webinar starts at 7:00 PDT\, 10:00 EDT\, 15:00 BST \nLearn how unbiased high-dimensional analysis can be seamlessly combined with AI-powered HALO workflows for multiplex images!\n\n\nSummary\n\n\n\n\nMultiplexed imaging generates rich datasets where extracting meaningful insights requires more than predefined gates.  \nIn this webinar\, we present a real-world use case analyzing tertiary lymphoid structures (TLS) in non-small cell lung cancer (NSCLC) using whole-slide multiplex immunofluorescence images acquired on the Orion™ platform (RareCyte). We demonstrate how standard HALO® workflows\, including AI-driven tissue classification and cell segmentation\, can be seamlessly combined with unbiased high-dimensional analysis\, all within the same software.  \nUsing K-means\, Phenograph\, and UMAP\, we explore phenotypic diversity within TLS from dense tumor regions and highly infiltrated zones. HALO® High Dimensional Analysis reveals biologically relevant differences between these zones beyond supervised phenotypes. Importantly\, the dynamic link between UMAP plots and the original tissue image provides biological meaning to clustering results and enables clear spatial validation.  \n\n\n\n\n\nLearning Objectives\n\n\n\n\n\nAssess sample cell composition “at a glance” using K-means and Phenograph. \nUse unsupervised analysis to quality control your analysis pipeline. \nNavigate interactively between the UMAP and biological image. \nApply an iterative\, data-driven strategy to identify and discover biologically relevant phenotypes. \n\n\n\n\nRegister Now\nPresenter\n\nDr. Ghislaine Lioux\nSenior Field Applications Scientist \nIndica Labs  \nDr. Ghislaine Lioux earned her PhD from the Spanish National Institute of Cardiovascular Research in Madrid as a Marie Curie Fellow\, where she studied molecular mechanisms of heart development. Ghislaine joined Indica Labs in 2020\, and in her current position as a Senior Field Applications Scientist she supports customers\, distributors\, and collaborators on the technical use of HALO software. 
URL:https://www.pathologynews.com/event/masterclass-unlock-cell-population-discovery-using-halo-high-dimensional-analysis/
LOCATION:Online
CATEGORIES:Live Online Webinar
ATTACH;FMTTYPE=image/jpeg:https://www.pathologynews.com/wp-content/uploads/2026/03/HDA-Webinar_800x600.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260329
DTEND;VALUE=DATE:20260402
DTSTAMP:20260826T165820
CREATED:20251119T163834Z
LAST-MODIFIED:20260107T114447Z
UID:100116901-1774742400-1775087999@www.pathologynews.com
SUMMARY:Focus on Microscopy 2026
DESCRIPTION:FOM2026 continues a long-standing (since 1988)\, yearly conference series on the latest innovations and developments in (optical) microscopy and their application in biology\, medicine\, and the material sciences. \nTopics\n\nTheory and practice of confocal and multiphoton-excitation microscopy\nInstrumentation and microscope design\nSuper-resolution microscopy\n3D and 4D live cell and tissue imaging\nAdaptive optics for microscopy\nLight sheet microscopy\nPhase/interference based microscopies\nOCT\, holography\, endoscopy\nAdvanced fluorescence imaging/spectroscopy: FRET\, FRAP\, FLIM\, FCS\, SOFI\nNew fluorescent probes\, proteins\, quantum dots\, single molecule imaging\nClearing and expansion techniques\nCoherent non-linear microscopies: SHG\, THG\, SFG\, CARS\nMulti-dimensional fluorescence and Raman spectroscopy imaging\nCorrelated microscopies e.g. light/electron\nLaser manipulation and tracking\, photo-activation\nFast acquisition\, automated and high-content microscopy\n3D image processing and visualization for multidimensional data\n\nRegister Now
URL:https://www.pathologynews.com/event/focus-on-microscopy-2026/
LOCATION:Kistamässan\, Arne Beurlings Torg 5\, Kista\, Stockholm\, 164 40\, Sweden
CATEGORIES:In Person Event
ATTACH;FMTTYPE=image/jpeg:https://www.pathologynews.com/wp-content/uploads/2025/11/Focus-on-Microscopy-2026.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260323
DTEND;VALUE=DATE:20260328
DTSTAMP:20260826T165820
CREATED:20250820T144848Z
LAST-MODIFIED:20250821T092815Z
UID:100115194-1774224000-1774655999@www.pathologynews.com
SUMMARY:National Imaging Informatics Course - Spring 2026
DESCRIPTION:0000Days00Hrs00Min00SecLearn the fundamentals of Imaging Informatics.\n\n\n\n\nNational Imaging Informatics Course (NIIC)\, Borne out of our collaboration with the RSNA + DPA\, NIIC is the first of its kind to delve into comprehensive fundamental principles in today’s real-world ecosystem of imaging informatics. \n\n\n\n\n\n\nGet working knowledge fast with SIIM’s National Imaging Informatics Course (NIIC)\n\n\n\n\n\nThe National Imaging Informatics Course (NIIC) is an accelerated\, week-long online experience for imaging informaticists seeking to better leverage their expertise towards a broader\, more holistic engagement within the field. \nBorne out of our collaboration with the RSNA and DPA\, NIIC is the first of its kind to delve into comprehensive fundamental principles in today’s real-world ecosystem of imaging informatics – in order to create enduring engagement and innovation within the field. \nParticipants develop a well more well-rounded understanding of the field\, demystify business cases and become more confident\, effective and valuable in the fast-changing medical and healthcare fields – plus earn up to 20 hours of SIIM IIP Credits doing so! \nIt is the perfect opportunity to introduce non-radiology professionals to the field of imaging informatics\, gain relevant understanding of how medical/healthcare systems work in total and impact how patients are cared for every day. \nThis NIIC Term is made possible by a partnership between the Radiological Society of North America (RSNA)\, the Digital Pathology Association (DPA) and the Society for Imaging Informatics in Medicine (SIIM); and initially funded by a grant from the Association of University Radiologists (AUR)\, this course has been developed by a team of faculty comprised of experts in imaging informatics from around the world. \n\n\n\nRegister Now\n\nImaging Informatics for All\n\nNIIC is open to anyone across the healthcare enterprise seeking to gain a baseline understanding of imaging informatics\, advance cross-functional skillsets and invest in their career goals. \n\nIndividual professionals\nPracticing physicians\nInstitutions\nTrainees at all levels\nFaculty\nIT experts\nIndustry partners\nand more!\n\n\n\n\n\n\nKey Features\n\nNIIC’s specialized curriculum is packed with relevant exercises (and tips) across the imaging informatics spectrum that are essential to modern medicine/healthcare including: \n\nClinical workflow\nHardware/software/networking requirements\nStandards\nPatient-centric radiology\nPACS archives\nBusiness aspects\nHot topics: AI\, mission-learning\, data science\, and 3D printing\n\nThe course is efficiently structured with intellectually stimulating pre-work and well-thought-out agendas plus an ample 3-month window to complete homework assignments.
URL:https://www.pathologynews.com/event/national-imaging-informatics-course-spring-2026/
LOCATION:Online
CATEGORIES:Online Training
ATTACH;FMTTYPE=image/jpeg:https://www.pathologynews.com/wp-content/uploads/2025/08/National-Imaging-Informatics-Course.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260321
DTEND;VALUE=DATE:20260327
DTSTAMP:20260826T165820
CREATED:20250918T152047Z
LAST-MODIFIED:20251117T125050Z
UID:100115674-1774051200-1774569599@www.pathologynews.com
SUMMARY:USCAP 2026
DESCRIPTION:0000Days00Hrs00Min00SecThe meeting will kick off on Saturday\, March 21 with the USCAP Honors and Dr. John Goldblum delivering the Maude Abbott Legacy lecture\, followed by the all-attendee welcome reception\, Gathering in the Grotto\, held on the San Antonio River Walk. \nOn Sunday\, March 22th\, select from over 40 education sessions offered by Companion Societies. These sessions cover the breadth and depth of pathology and are an excellent chance for you to network with colleagues. Starting Monday\, March 23rd\, attendees can select from a variety of programming from platforms to Luminaries to Interactive Microscopy sessions. In addition\, attendees can visit the exhibit hall to view the latest and greatest in pathology and attend seminars to get a deep dive into new products and technologies. On Tuesday\, March 24th\, join the Nathan Kaufman Timely Topics lecture on Generative and Agentic AI for Pathology delivered by Dr. Faisal Mahmood. \nWhy Attend the Annual Meeting\n\nConnect With Pathology Legends: USCAP’s Annual Meeting is where you go to hear pathology legends share their insights; where you run into the authors of your textbooks at an afternoon lecture; and where you meet the leading minds in pathology and join the conversation!\nReconnect With Old Friends and Make New Ones: Reconnect with friends from previous schools or positions; chat with your fellow attendees at social events; share insights around the microscope in Interactive Microscopy courses; or tour the poster hall and find a new collaborator.\nConnect Your Ideas: Before it’s a eye-opening article in a USCAP journal\, it might be a poster at the Annual Meeting. USCAP attracts the most cutting-edge research to its Poster Hall\, Moderated Poster Sessions\, and Platform Sessions. Come talk to the researchers in person and see how your ideas might align!\nSee How Exhibitors Connect Ideas and Action: Browse the latest technology and innovative products at the Exhibit Hall. You’ll hear from all of the leading companies in the field and glimpse the future of daily pathology practice. Visit pathology associations\, find new educational tools\, and more.\n\nRegister Now
URL:https://www.pathologynews.com/event/uscap-2026/
LOCATION:San Antonio\, TX\, USA\, San Antonio\, TX\, United States
CATEGORIES:In Person Event
ATTACH;FMTTYPE=image/jpeg:https://www.pathologynews.com/wp-content/uploads/2025/09/USCAP-2026.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20260319T170000
DTEND;TZID=Europe/London:20260319T180000
DTSTAMP:20260826T165820
CREATED:20260205T123809Z
LAST-MODIFIED:20260227T092746Z
UID:100118509-1773939600-1773943200@www.pathologynews.com
SUMMARY:The Cost of Disconnected Systems:  How to Leverage Pathology-Led Integrated Diagnostics on a Single Enterprise Platform
DESCRIPTION:0000Days00Hrs00Min00SecMost health systems are feeling the impact of fragmented diagnostic systems. Digital pathology may be live\, but radiology sits on a separate platform\, molecular data is handled elsewhere\, and AI tools often run as isolated pilots. These disconnects reduce the full potential of digital transformation and make effective collaboration more difficult. They also lead to avoidable delays\, add complexity to MDT meetings\, and increase IT and administrative burden. \nThis session takes a practical look at how digital pathology can anchor an integrated diagnostics strategy on a single enterprise imaging platform. We’ll focus on how leading AMCs and IDNs are approaching this transition\, why organizations are choosing an enterprise framework\, and what benefits they expect as they expand integrated workflows across pathology\, radiology\, and genomics. The discussion will highlight real-world decision-making\, early lessons learned\, and the long-term value of a unified diagnostic platform. \nLearning Objectives:\n\nHow fragmented diagnostic systems affect workflow\, collaboration\, and IT complexity\nWhy digital pathology is well positioned to lead an enterprise imaging strategy across departments\nHow health systems are approaching integrated diagnostics and the expected benefits of a single platform\n\nRegister NowPresenters\nTom Zarzycki \nAccount Manager\, MedicalDirector\, Strategic Development Digital Pathology | ImIT – Applications – Pathology \nJennifer Fralick  \nVice President of Anatomic Pathology and Clinical Laboratories at Stanford Health Care\, where she oversees all Stanford Medicine laboratory operations across the San Francisco Bay Area. In this role\, she has led major strategic initiatives\, including the implementation of two Digital Pathology platforms\, a comprehensive scanner ecosystem\, and Beaker AP. Under her leadership\, Stanford’s pathology and laboratory services expanded significantly to meet rising testing volumes and supported the growing complexity of molecular\, genetic\, and genomic diagnostics. She also played a central role in establishing and scaling Stanford’s COVID‑19 response. \nBefore joining Stanford\, Jennifer built a reputation as a highly regarded program manager at multiple academic medical centers. Her work included leading large‑scale implementations such as Radiology PACS systems\, Epic\, and automated chemistry lines—projects that required deep technical expertise\, operational insight\, and cross‑disciplinary coordination. \nOutside of her professional work\, Jennifer is an avid cyclist and runner. \nJonathan Shoemaker \nJonathan Shoemaker is an accomplished healthcare technology leader with nearly 30 years of experience advancing enterprise imaging\, workflow modernization\, and clinical informatics across major academic medical centers. As Executive Director of Imaging Systems and Services at Stanford Health Care\, he oversees a broad imaging portfolio and led the design of a highly resilient enterprise imaging platform that supports AI\, machine learning\, and real‑time research integration. Recently Mr. Shoemaker’s portfolio architected the latest Digital pathology platform that enables a full dicom deployment and informatics normalization model into Stanford digital pathology. \nPreviously\, at Sutter Health\, Jonathan directed one of the nation’s largest deconstructed PACS implementations\, consolidating 54 medical record systems and migrating 2PB of imaging data while building a new enterprise imaging support organization. His earlier consulting and engineering roles—spanning Ascendian Healthcare Consulting and GE Healthcare—shaped his reputation as a national expert in imaging architecture\, VNA strategy\, workflow optimization\, and complex multi‑system integration. \nRebecca Rojansky  \nDr. Rebecca Rojansky\, MD. PhD. is Associate Director for Clinical Pathology Informatics and Assistant Professor of Pathology at Stanford University School of Medicine. She is a practicing molecular and hematopathologist. Her work focuses on digital and computational pathology\, artificial intelligence\, and clinical informatics infrastructure to enable precision diagnostics.
URL:https://www.pathologynews.com/event/the-cost-of-disconnected-systems-how-to-leverage-pathology-led-integrated-diagnostics-on-a-single-enterprise-platform/
LOCATION:Online
CATEGORIES:PN Webinar
ATTACH;FMTTYPE=image/jpeg:https://www.pathologynews.com/wp-content/uploads/2026/02/sec-800x6000-updated-time.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20260317T110000
DTEND;TZID=Europe/Paris:20260317T150000
DTSTAMP:20260826T165820
CREATED:20260121T131830Z
LAST-MODIFIED:20260121T131830Z
UID:100117999-1773745200-1773759600@www.pathologynews.com
SUMMARY:Indica Labs’ Frankfurt HALO® User Group Meeting
DESCRIPTION:0000Days00Hrs00Min00SecLearn about the latest advancements from Indica Labs and how our customers are leveraging HALO platforms and Indica Labs services to advance their digital pathology.\n\n\nSummary\n\n\n\n\nIndica Labs is pleased to announce our Frankfurt HALO® User Group Meeting at Hilton Frankfurt Airport on 17 March from 11:00 – 16:00. \nOur program this year features guest speakers sharing insightful real-world applications of our HALO platforms as well as presentations from Indica Labs exploring the latest advancements in image analysis\, image management\, and services. \nWe welcome anyone who is interested in learning more about Indica Labs’ quantitative digital pathology solutions to register for the meeting today and save your place. You do not need to be a current Indica Labs customer to attend\, and the full agenda will be shared soon. \n\n\nRegister Now
URL:https://www.pathologynews.com/event/indica-labs-frankfurt-halo-user-group-meeting/
LOCATION:Hilton Frankfurt Airport\, THE SQUAIRE\, Am Flughafen\, Frankfurt am Main\, 60549\, Germany
ATTACH;FMTTYPE=image/jpeg:https://www.pathologynews.com/wp-content/uploads/2026/01/Frankfurt-User-Group-Meeting-800x600-1.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260309
DTEND;VALUE=DATE:20260313
DTSTAMP:20260826T165820
CREATED:20260305T111450Z
LAST-MODIFIED:20260305T111625Z
UID:100119112-1773014400-1773359999@www.pathologynews.com
SUMMARY:HIMSS USA 2026
DESCRIPTION:0000Days00Hrs00Min00SecHealthcare’s Premier Event\nGlobal Brands. Groundbreaking Ideas. Growth Opportunities. Genuine Connections. All Under One Roof.\nThe countdown to healthcare’s most transformative event has begun—and the prime opportunity to secure your spot starts now. HIMSS26 isn’t just a conference; it’s the epicenter of healthcare technology where groundbreaking solutions meet visionary minds. \nWhy Attend HIMSS 2026: Transform Healthcare Through Technology\nJoin the world’s largest healthcare IT gathering as we convene in Las Vegas from March 9-12\, 2026 for the HIMSS Global Health Conference & Exhibition. We’re bringing together healthcare IT professionals\, hospital executives\, technology vendors\, clinicians\, and industry leaders from around the globe to explore cutting-edge innovations that are reshaping the future of healthcare. \nThis premier event brings together the best minds in digital health\, creating the perfect opportunity to: \n\nDiscover Game-Changing Solutions\nGain Practical Knowledge\nBuild Valuable Connections\nMake the Most of Your HIMSS26 Experience\n\nRegister Now
URL:https://www.pathologynews.com/event/himss-2026/
LOCATION:The Venetian Convention & Expo Center\, 201\, Sands Avenue\, Las Vegas\, NV\, 89169\, United States
ATTACH;FMTTYPE=image/webp:https://www.pathologynews.com/wp-content/uploads/2026/03/HIMSS-USA-2026.webp
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20260305T130000
DTEND;TZID=UTC:20260305T140000
DTSTAMP:20260826T165820
CREATED:20260202T113505Z
LAST-MODIFIED:20260202T113505Z
UID:100118433-1772715600-1772719200@www.pathologynews.com
SUMMARY:Getting Started With HALO AI
DESCRIPTION:0000Days00Hrs00Min00SecThe webinar starts at 8:00 EST\, 13:00 GMT\, 14:00 CET \nLearn how to develop your own AI algorithms for segmentation\, classification\, and more using HALO AI\n\n\n\n\nSummary\n\n\n\n\nJoin us for an exciting webinar where you’ll embark on the journey of developing your own AI algorithms using HALO AI. This comprehensive session will guide you through creating and refining AI algorithms included with HALO AI\, providing invaluable tips\, tricks\, and best practices along the way.   \nWhether your focus is on tissue detection\, nuclear detection\, membrane detection\, object/cell phenotyping\, or slide quality control\, HALO AI has you covered. Additionally\, we will delve deeper into the capabilities of the AI Object Phenotyper\, an advanced tool designed to classify cells without the requirement for biomarker positivity.  \nDon’t miss this opportunity to enhance your AI skills and leverage the powerful features of HALO AI. We look forward to seeing you there!  \n\n\n\n\n\n\n\nLearning Objectives\n\n\n\n\n\nUnderstand the process of creating and training an algorithm using HALO AI \nLearn best practices for developing and training algorithms \nLearn about the capabilities and applications of AI-based object phenotyping\n\n\n\n\nRegister Now\nPresenter\n\nPedro Espinosa GonzalezSenior Field Applications Scientist – EMEA Indica Labs  \nPedro has a background in histology\, having worked in core facilities\, diagnostics units\, and research. During this time\, he specialized in cardiovascular\, neurological and oncological histology and developed an interest in image acquisition and image analysis giving him the opportunity to try different methods\, from WSI and confocal to super-resolution imaging and analysis. Pedro joined Indica Labs in 2022\, and in his current position as a Senior Field Applications Scientist provides applications support for HALO®\, HALO AI and HALO Link. 
URL:https://www.pathologynews.com/event/getting-started-with-halo-ai/
LOCATION:Online
CATEGORIES:Live Online Webinar
ATTACH;FMTTYPE=image/png:https://www.pathologynews.com/wp-content/uploads/2026/02/Intro-to-AI_PN800x600.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20260303T140000
DTEND;TZID=UTC:20260303T150000
DTSTAMP:20260826T165820
CREATED:20260220T113919Z
LAST-MODIFIED:20260225T133754Z
UID:100118825-1772546400-1772550000@www.pathologynews.com
SUMMARY:Analysis of computational tumor-infiltrating lymphocytes in breast cancer from the results of the TIGER challenge
DESCRIPTION:0000Days00Hrs00Min00SecThe Tissue Image Analytics (TIA) Centre hosts a seminar series for those interested in computational pathology. The series invites researchers and leaders in computational pathology and related fields to present their work and foster thought-provoking discussions. \nThis seminar features Mart van Rijthoven\, Radboud UMC\, Nijmegen\, The Netherlands. \nAbstract\nTumor-infiltrating lymphocytes (TILs) is a recognized prognostic biomarker in breast cancer. However\, poor interobserver agreement and limited reproducibility highlight the need for computational approaches. Despite advances\, adoption of computational models has been hindered by lack of standardized methods and robust benchmarks. To address this\, we launched TIGER\, an international competition to build open-source computational TILs (cTILs) models. Here\, we present a multi-centric analysis of cTILs methods on resections and biopsies from 3\,708 human epidermal growth factor receptor 2-positive (HER2+) and triple-negative breast cancers (TNBC) from clinical practice and phase 3 trials. We report benchmarks on image analysis performance\, show strong agreement of cTILs with pathologists\, and demonstrate positive association of cTILs with neoadjuvant therapy response in HER2+\, superior to visually scored TILs. We also show that cTILs add independent prognostic information to clinical variables in TNBC resections. Data\, methods and benchmarks are publicly available: https://tiger.grand-challenge.org/ \nRegister NowBio\nMart van Rijthoven did his PhD work in the Computational Pathology Group at Radboud University Medical Center\, focusing on deep learning for biomarker quantification in whole-slide images. His work includes the HookNet model\, quantification of tertiary lymphoid structures\, and few-shot learning for histopathology. He also developed the WholeSlideData package and co-organized the TIGER challenge.
URL:https://www.pathologynews.com/event/analysis-of-computational-tumor-infiltrating-lymphocytes-in-breast-cancer-from-the-results-of-the-tiger-challenge/
CATEGORIES:Live Online Webinar
ATTACH;FMTTYPE=image/png:https://www.pathologynews.com/wp-content/uploads/2026/02/TIA-Centre-Seminar-Series-Analysis-of-computational-tumor-infiltrating-lymphocytes-in-breast-cancer-from-the-results-of-the-TIGER-challenge.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20260224T083000
DTEND;TZID=UTC:20260224T183000
DTSTAMP:20260826T165820
CREATED:20251010T135639Z
LAST-MODIFIED:20251014T084718Z
UID:100116116-1771921800-1771957800@www.pathologynews.com
SUMMARY:PathVision 2026: The Convenzis NHS Pathology Strategy Conference North
DESCRIPTION:0000Days00Hrs00Min00SecClinical Diagnostics & Medical Sciences\nPathology services are integral to the NHS\, supporting over 70% of clinical diagnoses. As demands on pathology continue to grow\, innovation in digital pathology\, automation\, and workforce management is essential. This conference will explore the latest advancements and strategies for ensuring efficiency\, accuracy\, and service sustainability. \nKey Topics:\n\nDigital pathology and AI-driven diagnostics\nAddressing staff shortages and training needs\nThe future of pathology networks\nImproving turnaround times and service integration\nInvestment and funding for pathology services\n\nRegister NowWhy Attend?\nThis annual event brings together NHS pathology professionals\, laboratory managers\, and clinical leaders to explore cutting-edge developments in diagnostics. Join the conversation and be part of shaping the future of pathology services.
URL:https://www.pathologynews.com/event/pathvision-2026-the-convenzis-nhs-pathology-strategy-conference-north/
LOCATION:etc venues Manchester\, 8th Floor\, 11 Portland Street\, Manchester\, M1 3HU\, United Kingdom
CATEGORIES:In Person Event
ATTACH;FMTTYPE=image/jpeg:https://www.pathologynews.com/wp-content/uploads/2025/10/PathVision-2026-The-Convenzis-NHS-Pathology-Strategy-Conference-North.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20260224T080000
DTEND;TZID=UTC:20260224T090000
DTSTAMP:20260826T165820
CREATED:20260217T101432Z
LAST-MODIFIED:20260217T101432Z
UID:100118779-1771920000-1771923600@www.pathologynews.com
SUMMARY:Modernizing Pathology: Beyond Digital Pathology to Digital Health
DESCRIPTION:0000Days00Hrs00Min00SecJoin Virasoft at a time that suits you\, the webinar will be delivered at the following times: \n\nFeb 24 · 11:00 am (UTC+3)\, 8am GMT\, 3am EST\nFeb 24 · 3:00 pm (UTC+3)\, 12pm GMT\, 7am EST \nFeb 25 · 7:00 pm (UTC+3)\, 4pm GMT\, 11am EST\n\nThis webinar focuses on the challenges of traditional pathology workflows and the opportunities for scalable\, data-driven transformation. Learn how disconnected systems and paper-based processes — how a fully integrated digital pathology workflow can overcome these barriers. \nWhat you will learn:\n\nWhy pathology is a major opportunity for scalable digital transformation in healthcare\nHow paper-based workflows limit efficiency and traceability\nHow Virasoft unifies APLIS\, IMS\, AI\, and devices into one intelligent system\nEnd-to-end digital pathology from biopsy to report\nAutomatic AI trigger\, case prioritization\, and workflow orchestration\nHow centralized data enables business intelligence and smarter decisions\n\nWho should attend?\n\nPathologists and assistants\nLaboratory managers\nHospital IT teams\nHealthcare decision-makers\n\nRegister NowPresenters:\nÇisem Yazıcı\, Msc\nProduct Manager\, Virasoft \nBioengineer (MSc) with 8+ years in Digital Pathology\nLeads APLIS product vision\, design\, and international projects. \nGizem Solmaz\, Msc\nProduct Manager\, Virasoft\nBioengineer (MSc) with 7+ years in Digital Pathology\nLeads IMS & AI product design and international projects.
URL:https://www.pathologynews.com/event/modernizing-pathology-beyond-digital-pathology-to-digital-health/
LOCATION:Online
CATEGORIES:Live Online Webinar
ATTACH;FMTTYPE=image/png:https://www.pathologynews.com/wp-content/uploads/2026/02/Modernizing-Pathology-Beyond-Digital-Pathology-to-Digital-Health.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20260223T140000
DTEND;TZID=UTC:20260223T150000
DTSTAMP:20260826T165820
CREATED:20260220T095427Z
LAST-MODIFIED:20260224T103402Z
UID:100118821-1771855200-1771858800@www.pathologynews.com
SUMMARY:GSK AIML: From drug discovery to drug development
DESCRIPTION:0000Days00Hrs00Min00SecThe Tissue Image Analytics (TIA) Centre hosts a seminar series for those interested in computational pathology. The series invites researchers and leaders in computational pathology and related fields to present their work and foster thought-provoking discussions. \nThis seminar features Dr Danielle Belgrave\, GSK\, London\, UK. \nAbstract\nMultimodal machine learning models can learn shared representations of human biological state from molecular\, cellular\, imaging\, and clinical data to better understand disease mechanisms. These models are applied across clinical development to support biomarker discovery\, patient stratification\, and treatment response. Our work aims to build scalable AI to enable precision medicine. \nRegister NowBio\nDanielle Belgrave is a VP of AI/ML at GSK. Her experience spans conducting machine learning research and leading teams across academia and industry focused on scientific discovery and personalising interventions in health. She has previously worked at Google DeepMind\, Microsoft Research Cambridge\, UK and Imperial College London. She has a BSc in business mathematics and statistics from the London School of Economics and a master’s degree in statistics from University College London. Her PhD was at the University of Manchester in Machine Learning for Healthcare.
URL:https://www.pathologynews.com/event/gsk-aiml-from-drug-discovery-to-drug-development/
CATEGORIES:Live Online Webinar
ATTACH;FMTTYPE=image/jpeg:https://www.pathologynews.com/wp-content/uploads/2026/02/tia-centre-800x600-1.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20260219T160000
DTEND;TZID=Europe/London:20260219T170000
DTSTAMP:20260826T165820
CREATED:20260108T132253Z
LAST-MODIFIED:20260108T132253Z
UID:100117768-1771516800-1771520400@www.pathologynews.com
SUMMARY:Designing and Developing Automated Solutions Using the HALO GraphQL API
DESCRIPTION:0000Days00Hrs00Min00SecThe webinar starts at 8:00 PST\, 11:00 EST\, 16:00 GMT \nLearn the fundamentals of the HALO GraphQL API and how to design\, develop\, and implement time-saving automations\n\n\nSummary\n\n\n\n\nThis presentation introduces the foundational concepts of GraphQL\, beginning with a clear explanation of what GraphQL is and how it is implemented for the HALO Link platform. It then provides an overview of OpenID Connect (OIDC) while examining both the Client Credentials Flow and the Authorization Code Flow. The session demonstrates how OIDC authentication integrates with the HALO Link GraphQL API\, including a walkthrough of obtaining an access token using the Client Credentials Flow.  \nBuilding on these fundamentals\, the presentation unveils the design and development of an Automated Slide QC Process. Feature requirements are defined\, including: triggering the process via the ImageCatalogedEvent when an image is cataloged into HALO Link; automatically performing an Image QC analysis to compute percent normal tissue; and updating the corresponding HALO Link task to complete or failed based on a configurable threshold. A high-level architectural overview illustrates how the Automated Slide QC workflow interacts with both GraphQL and OIDC\, supported by a sequence diagram.  \nThe session concludes with a live coding demonstration in Python\, developing the Automated Slide QC Process in real time to show how the concepts\, APIs\, and authentication mechanisms come together in a practical implementation.  \n\n\n\n\n\nLearning Objectives\n\n\n\n\n\nLearn the fundamentals of GraphQL and how it is implemented in HALO Link \nLearn about OpenID Connect and how OIDC authentication works with the GraphQL API\nLearn how the discussed tools and concepts can be applied to automate slide QC \n\n\n\n\nRegister Now\nPresenter\n\nAndrew Gibson\nIntegrations Developer\nIndica Labs  \nAndrew Gibson is a software engineer from Albuquerque\, New Mexico. He earned his bachelor’s degree in Business Operations from the University of New Mexico before continuing his studies in computer science at Oregon State University. With nearly nine years at Indica Labs Inc.\, Andrew began his career as a front-end developer on HALO Link\, where he was responsible for implementing new UI features. He later transitioned to a back-end development team\, where he played a key role in designing\, implementing\, and maintaining the company’s GraphQL API. Currently\, Andrew works with Indica’s Cloud Services team as the lead Integrations Developer\, where he helps develop integration software solutions for HALO\, HALO Link\, and HALO AP with third-party software. 
URL:https://www.pathologynews.com/event/designing-and-developing-automated-solutions-using-the-halo-graphql-api/
LOCATION:Online
CATEGORIES:Live Online Webinar
ATTACH;FMTTYPE=image/png:https://www.pathologynews.com/wp-content/uploads/2026/01/GraphQL-API_PN800x600.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20260210T110000
DTEND;TZID=UTC:20260210T120000
DTSTAMP:20260826T165820
CREATED:20260206T154825Z
LAST-MODIFIED:20260206T154825Z
UID:100118580-1770721200-1770724800@www.pathologynews.com
SUMMARY:Multiomic Spatial Profiling and Artificial Intelligence: The Next Generation in Diagnostic Haematopathology?
DESCRIPTION:The Tissue Image Analytics (TIA) Centre hosts a seminar series for those interested in computational pathology. The series invites researchers and leaders in computational pathology and related fields to present their work and foster thought-provoking discussions. \nThis seminar features Dr Matthew Pugh from University of Birmingham\, Birmingham\, UK. \nAbstract\nMultiomic spatial profiling technologies are transforming primary tissue research\, yielding exciting new biological insights into disease processes. Despite this\, the benefits of this technology in clinical practice have not yet been realised. The diagnosis of blood cancer depends heavily on tissue biopsy histological assessment\, necessitating multiple immunohistochemical and in-situ hybridisation assays\, performed on separate tissue sections. This tissue-intensive approach can lead to tissue exhaustion and a repeat biopsy procedure. Multiomic spatial profiling techniques enable all these assays to  be performed on a single section of tissue\, facilitating complete diagnosis and streamlining laboratory and diagnostic processes. Computational and artificial intelligence-driven analysis of this data could facilitate pathological diagnosis and generate novel predictive and diagnostic biomarkers. In this talk we will explore the benefits and risks that multiomic spatial profiling combined with computational pathology could bring to the field of diagnostic haematopathology. \nRegister NowBio\nDr Pugh is an associate clinical professor and an honorary consultant haematopathologist based at the University of Birmingham. Following a BRC Molecular Pathology Fellowship at the ICR\, London\, and JSPS and BHP pre-doctoral fellowships\, he was awarded an MRC CRTF. Dr Pugh now leads a group researching EBV-driven lymphoproliferations\, specialising in the use of spatial profiling techniques to transform our understanding of lymphoproliferative disorders\, improve diagnosis\, and inform treatment.
URL:https://www.pathologynews.com/event/multiomic-spatial-profiling-and-artificial-intelligence-the-next-generation-in-diagnostic-haematopathology/
LOCATION:Online
CATEGORIES:Live Online Webinar
ATTACH;FMTTYPE=image/png:https://www.pathologynews.com/wp-content/uploads/2026/02/TIA-Centre-Seminar-Series-–-Multiomic-Spatial-Profiling-and-Artificial-Intelligence-The-Next-Generation-in-Diagnostic-Haematopathology.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20260202T140000
DTEND;TZID=Europe/London:20260202T150000
DTSTAMP:20260826T165820
CREATED:20260116T104926Z
LAST-MODIFIED:20260116T104926Z
UID:100117933-1770040800-1770044400@www.pathologynews.com
SUMMARY:TIA Centre Seminar Series – Computational Pathology Before and After the Foundation Model Era
DESCRIPTION:The Tissue Image Analytics (TIA) Centre hosts a seminar series for those interested in computational pathology. The series invites researchers and leaders in computational pathology and related fields to present their work and foster thought-provoking discussions. \nThis seminar features Dr Yang Hu from University of Leicester\, Leicester\, UK. \nAbstract\nComputational pathology is broadly utilized in both diagnosis and biomedical research\, offering data-driven approaches to augment traditional histopathological practice. Unlike conventional image analysis\, whole slide images (WSIs) present unique challenges due to their extreme size\, with weakly supervised learning at the slide level becoming a dominant paradigm. The interplay of multi-scale features\, ranging from cellular to tissue-level structures\, introduces subtle yet profound influences on the understanding of tissue morphology. In this talk\, I will begin by discussing cross-scale feature communication and then turn to the interpretability of patch-level representations in the era of pathology foundation models. Building on this\, I will explore how diverse morphological explanations arise and conclude with perspectives on the integration and coordination of multiple foundation models to advance computational pathology. \nRegister NowBio\nDr Yang Hu is a lecturer at the School of Computing and Mathematical Sciences\, University of Leicester\, having ended his contract as a Research Scientist at the Nuffield Department of Medicine\, University of Oxford. His research focuses on computational pathology\, medical image analysis\, and the development of lightweight and interpretable artificial intelligence methods.
URL:https://www.pathologynews.com/event/tia-centre-seminar-series-computational-pathology-before-and-after-the-foundation-model-era/
LOCATION:Online
CATEGORIES:Live Online Webinar
ATTACH;FMTTYPE=image/png:https://www.pathologynews.com/wp-content/uploads/2026/01/TIA-Centre-Seminar-Series-–-Computational-Pathology-Before-and-After-the-Foundation-Model-Era.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20260122T160000
DTEND;TZID=Europe/London:20260122T170000
DTSTAMP:20260826T165820
CREATED:20251212T110900Z
LAST-MODIFIED:20251212T110900Z
UID:100117398-1769097600-1769101200@www.pathologynews.com
SUMMARY:Highly Multiplexed Imaging Reveals CAF-immune Cell Niches in Cutaneous Carcinomas
DESCRIPTION:0000Days00Hrs00Min00SecRegister below! The webinar starts at 8 AM PST\, 4 PM GMT\, and 11 AM EST. \nLearn how HALO and HALO AI are helping expand our understanding of immune regulation by different subtypes of cancer-associated fibroblasts!\n\n\n\n\nSummary\n\n\n\n\nCancer-associated fibroblasts (CAFs) shape the tumor microenvironment (TME)\, influencing immune cell (IC) infiltration and anti-tumor activity. Three major CAF subtypes are identified in cutaneous carcinomas. Immunomodulatory CAFs (iCAFs)\, enriched in late-stage tumors\, express cytokines and chemokines that promote IC recruitment and activation. Matrix CAFs (mCAFs) produce extracellular matrix and ensheath tumor nests\, restricting IC entry. Myofibroblast-like CAFs (myoCAFs) resemble pericytes and contractile fibroblasts and likely support tissue remodeling and tumor vasculature.   \nKeratinocyte cancers\, including basal cell carcinomas (BCCs) and squamous cell carcinomas (SCCs)\, were profiled by Imaging Mass Cytometry using a panel targeting major myeloid\, lymphoid and CAF subsets\, including activation and exhaustion markers. Image analysis\, clustering\, and spatial mapping were performed with HALO\, Seurat\, and Squidpy\, enabling high-resolution definition of CAF niches.   \nSCCs harbored more immune cells than BCCs\, particularly lymphocytes. Tumor immune phenotypes—immune-desert\, -excluded\, and -inflamed—correlated with CAF composition: inflamed SCCs were enriched in iCAFs\, whereas immune-excluded BCCs and SCCs contained more mCAFs and myoCAFs; infiltrative BCCs were particularly enriched in myoCAFs. Spatial analysis mapped iCAFs adjacent to lymphocytes\, while myoCAFs formed fibroblast-rich stromal regions largely devoid of immune cells. These findings indicate that specific CAF subtypes differentially regulate immune infiltration and activation\, suggesting that targeting specific CAF subsets could enhance immunotherapy efficacy in cutaneous keratinocyte carcinomas and could be possibly translated to other keratinocyte cancers.  \n\n\n\n\n\n\n\n\nLearning Objectives\n\n\n\n\n\nLearn how to analyze highly multiplexed stainings in HALO \nLearn about the workflow applied in the study: Cell segmentation\, tissue classification\, cell phenotyping in R\, import of cell phenotypes back into HALO to conduct quality control and spatial analysis.\nLearn how cancer-associated fibroblast niches influence immune cell activation in skin cancer\n\n\n\n\n\nRegister NowPresenter\nBertram Aschenbrenner\, PhD \nPost-Doctoral Fellow \nLichtenberger Laboratory\, Medical University of Vienna   \nDr. Bertram Aschenbrenner studied molecular biology at the University of Vienna\, Austria and performed his master studies in the laboratory of Manuela Baccarini analyzing CRAF – Rok-α interactions. During his PhD studies in the research group of Ira-Ida Skvortsova at the Medical University of Innsbruck\, he dissected radioresistance mechanisms of mesenchymal breast carcinoma cells.  \nIn his current role as a post-doctoral fellow in the lab of Beate Lichtenberger at the Medical University of Vienna\, Bertram uses imaging mass cytometry\, 2D and 3D cell culture systems\, and skin cancer organoids harboring native tumor stroma to investigate different immunomodulatory functions of cancer-associated fibroblasts. 
URL:https://www.pathologynews.com/event/highly-multiplexed-imaging-reveals-caf-immune-cell-niches-in-cutaneous-carcinomas/
LOCATION:Online
CATEGORIES:Live Online Webinar
ATTACH;FMTTYPE=image/jpeg:https://www.pathologynews.com/wp-content/uploads/2025/12/Feature-image_800x600.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20260119T140000
DTEND;TZID=UTC:20260119T150000
DTSTAMP:20260826T165820
CREATED:20260107T121138Z
LAST-MODIFIED:20260107T121138Z
UID:100117733-1768831200-1768834800@www.pathologynews.com
SUMMARY:TIA Centre Seminar Series – Do androids dream of digital diagnoses? A pathologist’s perspective on digital and computational pathology.
DESCRIPTION:The Tissue Image Analytics (TIA) Centre hosts a seminar series for those interested in computational pathology. The series invites researchers and leaders in computational pathology and related fields to present their work and foster thought-provoking discussions. \nThis seminar features Dr Diana Montezuma Felizardo from IMP Diagnostics\, Portugal. \nAbstract\nWith a nod to Do androids dream of electric sheep? this talk will explore digital and computational pathology from a pathologist’s point of view. This session aims to be very practical\, bringing together a pot pourri of insights from real-world digital deployment and hands-on experience with computational research projects. The goal is to demystify the digital transition\, highlight pathologists’ contributions to CPath projects\, and emphasise the importance of multidisciplinarity in CPath research. \nRegister NowBio\nPathologist\, currently coordinating the R&D Unit at IMP Diagnostics (Portugal); invited junior researcher at the Cancer Biology and Epigenetics Group (CBEG) – Portuguese Institute of Oncology of Porto; board member and chair of the Scientific Committee of the European Society of Digital and Integrative Pathology (ESDIP). Medical degree from University of Coimbra (FMUC); PhD in Medical Sciences from ICBAS\, University of Porto.
URL:https://www.pathologynews.com/event/tia-centre-seminar-series-do-androids-dream-of-digital-diagnoses-a-pathologists-perspective-on-digital-and-computational-pathology/
LOCATION:Online
CATEGORIES:Live Online Webinar
ATTACH;FMTTYPE=image/png:https://www.pathologynews.com/wp-content/uploads/2026/01/TIA-Centre-Seminar-Series-–-Do-androids-dream-of-digital-diagnoses-A-pathologists-perspective-on-digital-and-computational-pathology.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20251210T163000
DTEND;TZID=Europe/London:20251210T173000
DTSTAMP:20260826T165820
CREATED:20251126T143234Z
LAST-MODIFIED:20251126T143234Z
UID:100117131-1765384200-1765387800@www.pathologynews.com
SUMMARY:Beyond the Image: Powering the Future of Life Sciences Research with Concentriq LS
DESCRIPTION:0000Days00Hrs00Min00SecJoin Proscia as they demo the latest Concentriq LS releases\, which are designed to help research teams analyze faster\, collaborate smarter\, and stay ready for the future of image-based discovery.\nThe latest Concentriq AP releases of v4.9 in June and v4.10 in September are focused on more than just new features. They are about providing the strategic foundation that every Anatomic Pathology lab needs to succeed in a digital world: \nEnterprise-Ready Scale & Security: See how multi-LIS support\, improved user-defined fields (UDFs)\, and self-service tools like in-app API key management enable flexible\, secure growth across sites. \nAgnostic Interoperability: Discover how expanded fluorescence imaging compatibility\, enhanced image lifecycle management\, and new AI integrations empower your lab to connect all scanners\, images\, and AI tools no matter the vendor. \nPathologist-Centric Workflow Optimization: View how navigation updates bring digital pathology even closer to the microscope\, from ergonomic and inverted panning to customizable zoom and review preferences. \nWhether you’re a multi-site health system or a private lab accelerating your digital transformation\, this live session will show how Concentriq AP’s latest releases deliver the interoperability\, scalability\, and usability needed to unlock new levels of performance and productivity. \nWant a sneak peek into the latest AP updates? Read our recent blog: Multi-Site LIS\, FL Images & More: Standout Updates in the Latest Concentriq AP Releases \nRegister NowPresenters\nAnisha Mohan\nProduct Manager\, Life Sciences\n\nRitida Nanda\nSenior Product Marketing Manager\, Life Sciences
URL:https://www.pathologynews.com/event/beyond-the-image-powering-the-future-of-life-sciences-research-with-concentriq-ls/
LOCATION:Online
CATEGORIES:Live Online Webinar
ATTACH;FMTTYPE=image/jpeg:https://www.pathologynews.com/wp-content/uploads/2025/11/Beyond-the-Image-Powering-the-Future-of-Life-Sciences-Research-with-Concentriq-LS-1.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20251210
DTEND;VALUE=DATE:20251212
DTSTAMP:20260826T165820
CREATED:20250513T103800Z
LAST-MODIFIED:20251007T103743Z
UID:100111941-1765324800-1765497599@www.pathologynews.com
SUMMARY:12th Digital Pathology & AI Congress: Europe
DESCRIPTION:0000Days00Hrs00Min00SecRegister using the link. There is also a Pathology News exclusive discount code available for this event \n\n\nThis internationally recognised meeting is the only meeting truly focused on the transformative power of Digital Pathology and the advances created by Artificial Intelligence and Machine Learning. Across the health sector and pharmaceutical/biotech industry the adoption of digital pathology is speeding up. It’s impact is being felt in primary diagnosis and clinical research  as well as the laboratory. \nRealisable benefits include:\n1. Enhanced Diagnostic Accuracy\n2. Increased Workflow Efficiency\n3. Accelerated Drug Discovery\n4. Improved Patient Outcomes\n5. Cost Savings \nNo wonder health services are implementing digital pathology to improve diagnostic services and patient outcomes particularly for better cancer diagnostics and treatment planning. While research institutions and pharmaceutical companies are leveraging AI to accelerate drug discovery and development\, leading to more innovative treatments reaching the market faster. \nIf you are just starting your digital journey\, or well down the road of harnessing the technology don’t miss this must-attend event  so you can maximize the potential of digital pathology and AI. \n\n\nRegister Now\n\n\n\n\n\n\n\nDiscount Code Available\nJoin our newsletter to receive the latest news\, promotional codes\, and much more… \n\n\n\n\n\n\n\n \n \n \n \n \n \n \n \n \n \n \n\n\n\n\n\n\n \n \n \n \n \n \n \n \n \n \n \n\n\n\n\n\n\n \n \n \n \n \n \n \n \n \n \n \n\n\n\n\n\n\n \n \n \n \n \n \n \n \n \n \n \n\n\n\n\n\n\n \n \n \n \n \n \n \n \n \n \n \n\n\n\n\n\n\n \n \n \n \n \n \n \n \n \n \n \n\n\n\n \n\n\nYou can unsubscribe anytime. For more details\, review our Privacy Policy. \n\n\n \n \n\nSubmit & Recieve Promo Code Via Email \n\nLoading… \n\n \n\n\n\n\nThank you!\nYou have successfully joined our subscriber list.
URL:https://www.pathologynews.com/event/12th-digital-pathology-ai-congress-europe/
ATTACH;FMTTYPE=image/jpeg:https://www.pathologynews.com/wp-content/uploads/2025/05/DPAI-London-25.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20251209T163000
DTEND;TZID=Europe/London:20251209T173000
DTSTAMP:20260826T165820
CREATED:20251125T120357Z
LAST-MODIFIED:20251125T120357Z
UID:100117077-1765297800-1765301400@www.pathologynews.com
SUMMARY:Scaling Smarter: Future-Proofing Pathology with Concentriq AP
DESCRIPTION:0000Days00Hrs00Min00SecJoin Proscia as they demo the latest Concentriq AP releases\, which are designed to help pathology teams scale securely\, work smarter\, and stay ready for the future of digital pathology.\nThe latest Concentriq AP releases of v4.9 in June and v4.10 in September are focused on more than just new features. They are about providing the strategic foundation that every Anatomic Pathology lab needs to succeed in a digital world: \nEnterprise-Ready Scale & Security: See how multi-LIS support\, improved user-defined fields (UDFs)\, and self-service tools like in-app API key management enable flexible\, secure growth across sites. \nAgnostic Interoperability: Discover how expanded fluorescence imaging compatibility\, enhanced image lifecycle management\, and new AI integrations empower your lab to connect all scanners\, images\, and AI tools no matter the vendor. \nPathologist-Centric Workflow Optimization: View how navigation updates bring digital pathology even closer to the microscope\, from ergonomic and inverted panning to customizable zoom and review preferences. \nWhether you’re a multi-site health system or a private lab accelerating your digital transformation\, this live session will show how Concentriq AP’s latest releases deliver the interoperability\, scalability\, and usability needed to unlock new levels of performance and productivity. \nWant a sneak peek into the latest AP updates? Read our recent blog: Multi-Site LIS\, FL Images & More: Standout Updates in the Latest Concentriq AP Releases \nRegister NowPresenter\nAmanda Coble\nSenior Director of Product
URL:https://www.pathologynews.com/event/scaling-smarter-future-proofing-pathology-with-concentriq-ap/
LOCATION:Online
CATEGORIES:Live Online Webinar
ATTACH;FMTTYPE=image/jpeg:https://www.pathologynews.com/wp-content/uploads/2025/11/Scaling-Smarter-Future-Proofing-Pathology-with-Concentriq-AP.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20251209
DTEND;VALUE=DATE:20251211
DTSTAMP:20260826T165820
CREATED:20250820T092147Z
LAST-MODIFIED:20250821T092553Z
UID:100115165-1765238400-1765411199@www.pathologynews.com
SUMMARY:Introduction to DICOM in Digital Pathology
DESCRIPTION:0000Days00Hrs00Min00SecPlan ahead to attend Introduction to DICOM in Digital Pathology\, a 2-day training\, delivered virtually through Zoom on Dec 9-10. (member rates available!) This hands-on training program provides an in-depth understanding of DICOM in digital pathology\, covering metadata\, image encoding\, storage solutions\, interoperability challenges\, and future trends. \nDigital pathology is rapidly evolving\, and DICOM (Digital Imaging and Communications in Medicine) is the key standard for interoperability and storage. This two-day hands-on training program provides an in-depth understanding of DICOM in digital pathology\, covering metadata\, image encoding\, storage solutions\, interoperability challenges\, and future trends. Participants will explore real-world applications through interactive exercises\, discussions\, and practical demonstrations. By the end of the course\, attendees will have the knowledge and skills to implement DICOM workflows in pathology environments\, improving data integration\, accessibility\, and compliance. Development of this course includes input from pathologists with first-hand experience in implementing DICOM in their current practices\, giving you a real-world perspective. \nLearning Objectives\nBy the end of this course\, participants will be able to: \n\nExplain the role of DICOM in digital pathology and how it differs from radiology applications.\nIdentify key metadata structures\, file formats\, and pixel data encoding relevant to pathology imaging.\nImplement and test DICOM Associations in combination with Storage/Storage Commitment.\nImplement and test DICOMweb APIs (WADO\, QIDO) for querying and retrieving pathology images.\nDesign and evaluate storage solutions\, including Vendor Neutral Archives (VNAs) for pathology labs.\nUtilize DICOM converters to transform pathology images and ensure interoperability with PACS.\nRecognize legal\, IT\, and standardization challenges in implementing DICOM-based pathology workflows.\nDiscuss how AI\, machine learning\, and emerging technologies are shaping the future of digital pathology.\n\nRegister NowFormat/Class Structure\nThis 2-day training will be delivered virtual live through Zoom on September 8th and 9th. Training on both days will start at 11:00am and end at 4:30 pm ET. There will be one 15-minute and one 30-minute break each day. \nWho Should Take This Course\nThis course is designed for: \n\nPathologists & Laboratory Technicians\nHealthcare IT Professionals & PACS Administrators\nMedical Imaging & Informatics Specialists\nSoftware Developers & Engineers in Digital Pathology\nRegulatory & Compliance Officers
URL:https://www.pathologynews.com/event/introduction-to-dicom-in-digital-pathology/
LOCATION:Online
CATEGORIES:Online Training
ATTACH;FMTTYPE=image/jpeg:https://www.pathologynews.com/wp-content/uploads/2025/08/Introduction-to-DICOM-in-Digital-Pathology.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20251208T140000
DTEND;TZID=Europe/London:20251208T150000
DTSTAMP:20260826T165820
CREATED:20251126T120420Z
LAST-MODIFIED:20251126T120420Z
UID:100117143-1765202400-1765206000@www.pathologynews.com
SUMMARY:The DIAGGRAFT project - Developing AI for kidney transplant diagnostics
DESCRIPTION:0000Days00Hrs00Min00SecThe Tissue Image Analytics (TIA) Centre hosts a seminar series for those interested in computational pathology. The series invites researchers and leaders in computational pathology and related fields to present their work and foster thought-provoking discussions. \nThis seminar features Dr Linda Studer from Radboud UMC\, Nijmegen\, The Netherlands. \nAbstract\nGiven the significant increase in kidney transplantations\, maximizing long-term transplant survival is even more important. While histopathologic assessment of biopsies remains the diagnostic gold standard\, the current diagnostic classification system (Banff Lesion Scores) possesses considerable observer variability\, is mostly qualitative\, and lacks granularity in key areas\, therefore challenging biopsy assessment. To address these limitations\, the DIAGGRAFT project aims to develop and clinically validate deep learning-based tools for renal transplant histopathology. The first step of the project was the development of tissue segmentation algorithms for the key renal compartments. The second step focused on automating the objective quantification of inflammatory cells necessary for reproducible Banff scoring\, for which we launched the MONKEY (Machine-learning for Optimal detection of iNflammatory cells in the KidnEY) computational challenge. Currently\, we are running a validation study with over 40 pathologists to assess the clinical utility\, efficiency\, and integration readiness of these algorithms. \nRegister NowBio\nLinda Studer holds a PhD in Computer Science from the University of Fribourg\, Switzerland\, and has an academic background in life sciences. Her PhD mainly focused on the use of Graph Neural Networks for colorectal cancer histopathology. Currently\, she is a Postdoctoral Researcher within the Computational Pathology Group (CPG) at Radboudumc. She is working on the DIAGGRAFT project\, which focuses on developing AI solutions for kidney transplant diagnostics. As part of this project\, she led the MONKEY computational challenge (a MIDL 2025 challenge)\, which focused on the detection and classification of inflammatory cells in PAS-stained kidney transplant biopsies. She was also an organizer for the COMPAYL workshop at MICCAI 2024 and 2025.
URL:https://www.pathologynews.com/event/the-diaggraft-project-developing-ai-for-kidney-transplant-diagnostics/
LOCATION:Online
CATEGORIES:Live Online Webinar
ATTACH;FMTTYPE=image/png:https://www.pathologynews.com/wp-content/uploads/2025/11/TIA-Centre-Seminar-Series-–-The-DIAGGRAFT-project-Developing-AI-for-kidney-transplant-diagnostics.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20251203
DTEND;VALUE=DATE:20251205
DTSTAMP:20260826T165820
CREATED:20250711T145007Z
LAST-MODIFIED:20250731T142519Z
UID:100114341-1764720000-1764892799@www.pathologynews.com
SUMMARY:EPIC Technology Meeting on Cancer Pathology\, Therapy and Surgery at Gustave Roussy
DESCRIPTION:0000Days00Hrs00Min00SecPhotonics technologies have shown great promise in advancing both the diagnosis and therapy of cancer\, offering highly precise\, non-invasive and\, in some cases\, real-time solutions. Techniques such as optical coherence tomography (OCT)\, fluorescence imaging\, and Raman spectroscopy enable early detection and detailed imaging of tumors at a cellular level. Their goal is to overcome some of the disadvantages of the traditional methods in terms of accuracy and speed of the diagnosis. Novel imaging techniques can also offer new advantages in intraoperative margin assessment in surgical oncology. For cancer therapy\, photonics plays a critical role in approaches like photodynamic therapy\, where light is used to activate photosensitive drugs that selectively target and destroy cancer cells. And laser sources can be used on surgical applications due to their capability to destroy tumors with minimal damage to surrounding healthy tissue. The integration of photonics with molecular imaging and targeted drug delivery systems is also enhancing the precision of cancer treatments\, improving outcomes\, and minimizing side effects. \nThis meeting will bring together medical doctors from different departments to discuss with the photonics community the actual status of the solutions they use and the remaining challenges and needs. From this discussion\, integrators\, manufacturing of complete systems and components manufacturers will understand the way to improve their developments to address the specific problems of the medical community. In order to support companies in this challenging process\, a specific session on regulations\, certifications and hospital management needs will be organized to have new recommendations and advice from experts in these topics. \nRegister NowMeet Our Partner
URL:https://www.pathologynews.com/event/epic-technology-meeting-on-cancer-pathology-therapy-and-surgery-at-gustave-roussy/
LOCATION:Gustave Roussy Cancer Campus\, Paris\, France
CATEGORIES:In Person Event
ATTACH;FMTTYPE=image/jpeg:https://www.pathologynews.com/wp-content/uploads/2025/07/EPIC-Technology-Meeting-on-Cancer-Pathology-Therapy-and-Surgery-at-Gustave-Roussy.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20251202T140000
DTEND;TZID=Europe/London:20251202T150000
DTSTAMP:20260826T165820
CREATED:20251021T100345Z
LAST-MODIFIED:20251021T100412Z
UID:100116308-1764684000-1764687600@www.pathologynews.com
SUMMARY:Navigating the Future: Implementing Digital Pathology
DESCRIPTION:0000Days00Hrs00Min00SecRegister below! The webinar starts at 2 PM GMT\, 3 PM CET\, and 9 AM EST. \nJoin us for an insightful conversation on what it truly takes to implement a successful\, scalable digital pathology service. \nIn this webinar\, Christopher Parry\, Digital Pathology Sales Specialist at Roche\, and Paul Flavell\, Programme and Portfolio Manager\, draw on their combined expertise in cellular pathology\, cloud migration\, and digital transformation to explore the journey from vision to implementation. \nThrough a presentation and conversational Q&A format\, they’ll unpack the key stages of digital adoption from defining why digitisation matters\, to managing integration\, networking\, and storage requirements\, and overcoming real-world challenges through strong partnerships and collaboration. \nLearning Objectives\n\nWhy a network-wide digital pathology service requires more than just hardware.\nHow strong relationships have driven successful digital pathology deployment.\nWhat benefits are already being realised and what the future holds as AI and algorithmic tools become part of routine diagnosis.\n\nRegister NowPresenters\nChristopher Parry \nWith over 10 years experience within Cellular Pathology\, Chris is now a Digital Pathology Sales Specialist at Roche\, Chris is passionate about leveraging digital pathology and AI to transform cellular pathology. With a focus on driving diagnostic certainty and alleviating the significant backlogs within the field. Background includes roles in tissue diagnostics sales\, as an applications consultant\, and as a biomedical scientist in both the NHS and private sectors. \nPaul Flavell \nPaul is a highly experienced Programme and Portfolio manager\, delivering large complex data center migrations\, cloud migrations and cloud optimisation programmes of work across multiple industries sectors. 5 years with Roche leading teams to design and deliver digital solutions.
URL:https://www.pathologynews.com/event/navigating-the-future-implementing-digital-pathology/
LOCATION:Online
CATEGORIES:PN Webinar
ATTACH;FMTTYPE=image/jpeg:https://www.pathologynews.com/wp-content/uploads/2025/10/ROC-WEB0-Featured-image-.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20251126T140000
DTEND;TZID=Europe/London:20251126T150000
DTSTAMP:20260826T165820
CREATED:20251112T171912Z
LAST-MODIFIED:20251112T171912Z
UID:100116779-1764165600-1764169200@www.pathologynews.com
SUMMARY:Optimizing the pathology workflow with Aiforia® Breast Cancer Suite
DESCRIPTION:Join Aiforia to learn how AI technology can enhance precision\, speed\, and diagnostic accuracy in breast cancer diagnostics. \nPathologist and Aiforia’s Medical Director\, Richard Doughty\, will discuss his experiences working with breast cancer tissue samples in routine diagnostics. He will showcase a typical BC workflow with and without AI and explain how Aiforia’s AI seamlessly integrates to enhance every step\, from sample analysis to diagnosis. \nAiforia®️ Breast Cancer Suite is the most comprehensive AI toolkit for breast cancer diagnostics\, supporting the entire diagnostic workflow. It consists of six CE-IVD marked AI solutions with an optimized interactive user interface that assists pathologists in the histological grading of breast cancer\, assessment of breast cancer IHC markers\, and the detection of lymph node metastasis. The user can review\, verify\, and modify results\, ensuring the highest quality of output. \nWho should join?\n\nPathologists involved in the routine diagnostic workflow for breast cancer\nOncologists and other clinicians who rely on accurate and timely breast cancer diagnostics for treatment planning\nLaboratory directors and administrators interested in implementing AI-powered digital pathology tools to improve efficiency and precision\nAnyone involved in breast cancer diagnostics who wants to learn about the practical application of AI in histological grading\, IHC marker assessment\, and metastasis detection\n\nRegister NowSpeakers\nRichard Doughty\, DVM\, MD\, MSc\nMedical Director at Aiforia Technologies \n\nConsulting pathologist at Oslo University Hospital\nMedical doctor and specialist in pathology with extensive diagnostic experience.\nQualified veterinarian with pathology expertise in pharmaceutical research and development.\n\nRute Pedrosa\, PhD\nSenior Field Application Scientist\, Aiforia Technologies \n\nHas worked at Aiforia for 2.5 years\nPhD at Erasmus University Rotterdam\, focusing on the pathogenesis of brain metastatic disease
URL:https://www.pathologynews.com/event/optimizing-the-pathology-workflow-with-aiforia-breast-cancer-suite/
LOCATION:Online
CATEGORIES:Live Online Webinar
ATTACH;FMTTYPE=image/jpeg:https://www.pathologynews.com/wp-content/uploads/2025/11/Optimizing-the-pathology-workflow-with-Aiforia®-Breast-Cancer-Suite.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20251125T150000
DTEND;TZID=Europe/London:20251125T160000
DTSTAMP:20260826T165820
CREATED:20251106T111722Z
LAST-MODIFIED:20251106T111723Z
UID:100116685-1764082800-1764086400@www.pathologynews.com
SUMMARY:AI in Clinical Digital Pathology: An introduction and live demonstrations of Aperio HALO AP and Aperio AI Store
DESCRIPTION:0000Days00Hrs00Min00SecRegister below! The webinar starts at 4 PM CET\, 3 PM GMT\, and 10 AM EST. \nJoin Leica Biosystems for a dynamic one-hour session exploring how cutting-edge software and artificial intelligence are transforming clinical digital pathology. This webinar will showcase live demonstrations of the Aperio HALO AP Image Management Solution and Aperio AI Store. \n\nBuilding Now for Tomorrow’s Future: Rob Monroe\, MD\, PhD\, VP & Chief Scientific Officer\, Oncology\, Danaher Diagnostics\, Chief Medical Officer\, Leica Biosystems\nIntroduction and Demonstrations for Aperio HALO AP and Aperio AI Store: Bryce Brown\, Director\, Product Management\, Leica Biosystems\nLive Audience Q & A: Linda Fildey\, Senior Manager\, Global Customer Advocacy\, Leica Biosystems (attendees are invited to participate in a live Q&A session with our experts to dive deeper into the technologies and innovations discussed).\n\nWebinar learning objectives:\n\nDiscover how AI tools are empowering pathologists and histotechnologists with advanced tools to enhance diagnostic precision\, streamline workflows\, and support better patient outcomes.\nExplore the capabilities of Aperio HALO AP and Aperio AI Store through live demonstrations\, highlighting practical applications in real-world pathology settings.\nPractical considerations on the importance of building future-ready digital pathology infrastructure\n\nRegister NowPresenters\nRob Monroe\, MD\, PhD\, VP & Chief Scientific Officer\, Oncology\, Danaher Diagnostics\, Chief Medical Officer\, Leica Biosystems \nRob joined Danaher in January 2022 to help drive oncology initiatives for the Diagnostics Platform and lead Medical Affairs at Leica Biosystems. Over the course of his career\, Rob has served in multiple Chief Medical Officer and Medical Director roles for diagnostics companies including Bio-Techne\, Advanced Cell Diagnostics\, Veracyte\, and BioImagene. Before joining industry\, Rob practiced pathology in the Central Coast of California following residency/fellowship training in Pathology at UCLA and Stanford and MD/PhD training at Harvard Medical School. \nBryce Brown\, Director\, Product Management\, Leica Biosystems \nBryce Brown is an accomplished leader in digital pathology and molecular diagnostics\, currently serving as Director of Product Management\, Digital Pathology at Leica Biosystems. With over a decade of experience at Leica Biosystems\, Bryce has held multiple strategic roles\, including leadership in Artificial Intelligence and Machine Learning\, where he helped shape product innovation across remote teams in the U.S.. Bryce has also worked as a Cytogenetic Hematological Chromosome Technologist at the Mayo Clinic\, where he contributed to high-impact clinical diagnostics in hematological disorders. He holds a Bachelor of Science in Cellular and Molecular Biology from Winona State University. \nLinda Fildey\nSenior Manager\, Global Customer Advocacy\nLeica Biosystems
URL:https://www.pathologynews.com/event/ai-in-clinical-digital-pathology-an-introduction-and-live-demonstrations-of-aperio-halo-ap-and-aperio-ai-store/
LOCATION:Online
CATEGORIES:PN Webinar
ATTACH;FMTTYPE=image/jpeg:https://www.pathologynews.com/wp-content/uploads/2025/11/FINAL-LSB-WEB8-800X600.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20251121T110000
DTEND;TZID=Europe/London:20251121T120000
DTSTAMP:20260826T165821
CREATED:20251103T163125Z
LAST-MODIFIED:20251103T163125Z
UID:100116619-1763722800-1763726400@www.pathologynews.com
SUMMARY:TIA Centre Seminar Series - Pathology knowledge-guided AI models in computational pathology
DESCRIPTION:The Tissue Image Analytics (TIA) Centre hosts a seminar series for those interested in computational pathology. The series invites researchers and leaders in computational pathology and related fields to present their work and foster thought-provoking discussions. \nThis seminar features Professor Jin Tae Kwak from Korea University\, Seoul\, South Korea. \nAbstract\nComputational pathology is undergoing a profound transformation driven large-scale artificial intelligence (AI)\, particularly the seamless integration of multiple data modalities through multimodal large language models (MLLMs). In this talk\, I will present our group’s recent efforts in developing knowledge-guided computational pathology tools that utilize vision-language models for various diagnostic tasks. I will discuss how vision-language models\, combined with expert knowledge\, can aid in analyzing complex tissue patterns\, enhancing interpretability\, and achieving accurate and reliable diagnostic performance. \nRegister NowBio\nJin Tae Kwak received his Ph.D. in Computer Science from University of Illinois at Urbana-Champaign\, USA in 2012. He earned his Masters of Science degree in Electrical and Computer Engineering from Purdue University\, USA in 2007 and his Bachelor of Engineering degree in Electrical Engineering from Korea University\, Korea in 2005. In 2012\, He joined Center for Interventional Oncology\, Clinical Center\, National Institutes of Health\, USA as a Research Fellow. He served as a tenure-track faculty member in the department of Computer Science and Engineering at Sejong University from March 2016 to August 2020. He joined School of Electrical Engineering at Korea University in September 2020. His research interests include multimodal medical imaging\, digital and computational pathology\, and large-scale and efficient AI systems for medicine
URL:https://www.pathologynews.com/event/tia-centre-seminar-series-pathology-knowledge-guided-ai-models-in-computational-pathology/
LOCATION:Online
CATEGORIES:Live Online Webinar
ATTACH;FMTTYPE=image/png:https://www.pathologynews.com/wp-content/uploads/2025/11/TIA-Centre-Seminar-Series-–-Pathology-knowledge-guided-AI-models-in-computational-pathology.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20251120T160000
DTEND;TZID=Europe/London:20251120T170000
DTSTAMP:20260826T165821
CREATED:20251009T090234Z
LAST-MODIFIED:20251009T090234Z
UID:100115983-1763654400-1763658000@www.pathologynews.com
SUMMARY:HistoWiz x PathologyOutlines: Seamless Digital Slide Integration with PathologyMap™
DESCRIPTION:0000Days00Hrs00Min00SecJoin HistoWiz and PathologyOutlines.com for an inside look at how their new partnership is transforming digital pathology publishing. This webinar will showcase how PathologyMap™\, HistoWiz’s secure digital slide management platform\, now integrates with PathologyOutlines.com to make research articles more interactive and accessible. Attendees will see firsthand how authors can easily upload digital slides\, embed high-resolution images directly into articles\, and provide readers with frictionless access to pathology content. Learn how this collaboration is setting a new standard for open-access education and discover tools that simplify workflows for authors\, readers\, and the pathology community at large. \nLearning Objectives\n\nUnderstand how PathologyMap™ integrates with PathologyOutlines.com to simplify digital slide sharing and publishing.\nIdentify the benefits of embedding interactive whole slide images within research articles for both authors and readers.\nExplore how this collaboration supports open-access education and democratizes access to pathology data worldwide.\nRecognize opportunities to adopt digital pathology tools that enhance learning\, research dissemination\, and clinical insights.\n\nRegister NowSpeakers\nAkash Parvatikar\, PhD \nAI Scientist and Product Manager\, HistoWiz \nKristi Marie \nManaging Editor\, PathologyOutlines.com
URL:https://www.pathologynews.com/event/histowiz-x-pathologyoutlines-seamless-digital-slide-integration-with-pathologymap/
LOCATION:Online
CATEGORIES:PN Webinar
ATTACH;FMTTYPE=image/jpeg:https://www.pathologynews.com/wp-content/uploads/2025/10/Histowiz-webinar-featured-image.jpeg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20251119
DTEND;VALUE=DATE:20251122
DTSTAMP:20260826T165821
CREATED:20251014T140535Z
LAST-MODIFIED:20251014T140535Z
UID:100116192-1763510400-1763769599@www.pathologynews.com
SUMMARY:Carrefour Pathologie 2025
DESCRIPTION:The congress took place in a beautifully rehabilitated venue\, designed to meet expectations and widely appreciated by participants. The 2024 edition was a great success\, bringing together 1\,486 participants (a record!) and receiving excellent feedback from both pathologists and exhibitors. \nCARREFOUR 2025 will once again bring together professionals in Pathological Anatomy and Cytology for a unique moment of learning\, exchange\, and collaboration. The event will be held in person\, with all sessions available afterwards as podcasts for registered participants via the Carrefour media library. \nRegister NowKey Features of CARREFOUR 2025\nScientific Programme designed by Professor Séverine Valmary-Dégano and the scientific committee. \nHistoseminars on: \n\nColorectal tumors\nThyroid pathology\nOvarian pathology\n\nConferences by world-renowned French and international pathologists covering: \n\nFrance Genomics 2025 program\nEthics and artificial intelligence\nPulmonary cytology and mediastinal pathology\n\nSymposia Topics \n\nTheranostic markers\nEcological transition and quality\nBilio-pancreatic cytology\nFeto-placental pathology\nOrgan transplant rejection\n\nInteractive Session \n\nFocused on the management of prostate biopsies — one of the most anticipated sessions of the event\n\nAIP Day (Friday) \n\nTheme: Pulmonary Tumor and Pseudotumoral Pathology\n\nMedico-Technical Sessions \n\nThe Macroscopic Technician: Crossed Views and Feedback\nThe Cyber-ACP Attack: Action / Reaction / Anticipation
URL:https://www.pathologynews.com/event/carrefour-pathologie-2025/
LOCATION:CNIT Forest in Paris la Défense\, 2 Le PARV de la Défense\, Paris\, 92800\, France
CATEGORIES:In Person Event
ATTACH;FMTTYPE=image/jpeg:https://www.pathologynews.com/wp-content/uploads/2025/10/Carrefour-Pathologie-2025.jpg
END:VEVENT
END:VCALENDAR